Full Text View
Tabular View
No Study Results Posted
Related Studies
Study Comparing Premarin®/MPA, PREMPRO® and Provera® in Healthy Postmenopausal Women
This study is currently recruiting participants.
Study NCT00543634   Information provided by Wyeth
First Received: October 3, 2007   Last Updated: July 8, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Postmenopause
Interventions listed in this trial
Premarin/MPA
Provera 10 mg
Additional drug interventions recognized in this trial
Estrogens, Conjugated (USP)
Medroxyprogesterone
Medroxyprogesterone 17-Acetate
More general drug interventions related to this trial
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Contraceptive Agents
Contraceptive Agents, Female
Contraceptive Agents, Male
Contraceptives, Oral
Contraceptives, Oral, Synthetic
Estrogens
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Pharmacologic Actions
Physiological Effects of Drugs
Reproductive Control Agents
Therapeutic Uses
Sponsors listed in this trial
Wyeth
MDS Pharma Services


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services